The Ministry of Health & Family Welfare has announced a conditional extension for small and medium pharmaceutical manufacturers to comply with the revised Schedule M (Good Manufacturing Practices provisions). Manufacturers with an annual turnover of ₹250 crores or less now have until 31st December, 2025 to meet the updated regulatory standards.
